International Journal of Neuropsychopharmacology

SJR Rank #2,050H-index: 135SJR: 1.651Best quartile: Q1Open AccessAPC: US$2,693Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Oxford University Press

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.450.91.351.8

Subject Categories

  • PharmacologyQ1
  • Pharmacology (medical)Q1
  • Psychiatry and Mental HealthQ1

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Neurotransmitter Receptor Influence on BehaviorTryptophan and brain disordersTreatment of Major DepressionSchizophrenia research and treatmentNeuroscience and Neuropharmacology ResearchStress Responses and CortisolBipolar Disorder and TreatmentReceptor Mechanisms and SignalingFunctional Brain Connectivity StudiesNeuroendocrine regulation and behavior

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs060120180240

Documents per Year

202220250255075100

Detailed Information

ISSN

1461-1457, 1469-5111

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.67

References per Document

61.13

Coverage

1998-2026

Scope

The central focus of the journal is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology and neuropsychology. Emphasis is given to original research (in the form of full-length papers and brief reports), which is of wide interest and clearly advances the field. Selected review articles and papers that highlight novel trends and perspectives are also considered.

Metrics from SCImago Journal Rank 2025. View on SCImago